Posted by Michael Wonder on 24 Feb 2022
EMA recommends authorisation of booster doses of Comirnaty from 12 years of age
24 February 2022 - EMA’s CHMP has recommended that a booster dose of the COVID-19 vaccine Comirnaty may be given where appropriate to adolescents from 12 years of age.
Comirnaty is already authorised in the EU as a 2 dose primary course in adolescents (as well as adults and children from 5 years of age) and a booster dose is currently authorised from 18 years of age.
